Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymopentin in Asymptomatic HIV
NCT00002109Phase 3Completed
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of thymopentin in human immunodeficiency virus infection (HIV). Status: completed.
02
Drugs
thymopentin
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002109.